These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2846937)

  • 1. Antihypertensive efficacy of enalapril maleate on impaired renal function.
    Coratelli P; Buongiorno E; Giannattasio M; Passavanti G
    Kidney Int Suppl; 1988 Sep; 25():S204-6. PubMed ID: 2846937
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.
    Abraham PA; Opsahl JA; Halstenson CE; Keane WF
    Arch Intern Med; 1988 Nov; 148(11):2358-62. PubMed ID: 2847667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function.
    Saelen MG; Prøsch LK; Gudmundsdottir H; Dyrbekk D; Helge Hunderi O; Arnesen E; Paulsen D; Skjønsberg H; Os I
    Blood Press; 2005; 14(3):170-6. PubMed ID: 16036497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
    Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
    Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spirapril in chronic renal failure.
    Stein G; Sierakowski B; Jansa U; Haufe CC
    Blood Press Suppl; 1994; 2():54-60. PubMed ID: 8061847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined drug therapy is better: successfully protecting elderly hypertensive patients].
    Trenkwalder P
    MMW Fortschr Med; 2008 Jul; 150(28-31):48-9. PubMed ID: 19009707
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive effects of metolazone (zaroxolyn).
    Materson BJ; Oster JR; Perez-Stable EC
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):890-6. PubMed ID: 4214663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conservative therapy of chronic renal failure].
    Reubi F
    Helv Med Acta Suppl; 1969; 49():88-99. PubMed ID: 4192458
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of enalapril on renal function in patients with severe chronic kidney disease.
    Vernaglione L
    Nephrol Dial Transplant; 2007 Feb; 22(2):665-6. PubMed ID: 16951420
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pharmacology of diuretics with special reference to furosemide and ethacrynic acid].
    Prandota J
    Postepy Hig Med Dosw; 1980; 34(1):47-74. PubMed ID: 6782558
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacotherapy and renal function in the aged].
    Fabre J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1183-90. PubMed ID: 4585245
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A renoprotective effect of enalapril in chronic transplantation nephropathy].
    Tomilina NA; Bagdasarian AR; Stoliarevich ES; Sukhanov AV; Fedorova ND; Il'inskiĭ IM; Tyrin VV; Frolov AV
    Ter Arkh; 2004; 76(9):47-53. PubMed ID: 15532377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
    Giverhaug T; Falck A; Eriksen BO
    J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bumetanide in renal insufficiency].
    Humair L
    Schweiz Med Wochenschr; 1982 Feb; 112(9):310-4. PubMed ID: 7079713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
    Kamper AL; Strandgaard S; Leyssac PP
    Ugeskr Laeger; 1993 Aug; 155(31):2406-9. PubMed ID: 8346593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.